Terms: = Leukemia AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
668 results:
1. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
[TBL] [Abstract] [Full Text] [Related]
2. Saracatinib prompts hemin-induced K562 erythroid differentiation but suppresses erythropoiesis of hematopoietic stem cells.
Ding L; Chen D; Li Y; Xie Y; Sun X; Wang D
Hum Cell; 2024 May; 37(3):648-665. PubMed ID: 38388899
[TBL] [Abstract] [Full Text] [Related]
3. [How I manage polycythemia].
Lombardo G; Hafraoui K; Beguin Y; Vertenoeil G
Rev Med Liege; 2024 Feb; 79(2):110-115. PubMed ID: 38356428
[TBL] [Abstract] [Full Text] [Related]
4. Role of PI3K/Akt/mTOR pathway-mediated macrophage autophagy in affecting the phenotype transformation of lung fibroblasts induced by silica dust exposure.
DU Y; Huang F; Guan L; Zeng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1152-1162. PubMed ID: 37875355
[TBL] [Abstract] [Full Text] [Related]
5. Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial.
Barbosa-Cortés L; Martínez-Vieyra X; Mejía-Aranguré JM; López-Alarcón M; Martin-Trejo J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Atilano-Miguel S; Rodríguez-Cruz M; Maldonado-Hernández J; Añoveros-Barrera A; Solís-Labastida KA; Espinoza-Hernández L; Nuñez-Villegas NN; Jiménez-Hernández E; Bautista-Martínez BA; Juárez-Moya A; Hernández-Piñón Z; Pérez-Casillas RX
Clin Nutr; 2023 Sep; 42(9):1759-1769. PubMed ID: 37549598
[TBL] [Abstract] [Full Text] [Related]
6. Heterogeneity in leukemia cells that escape drug-induced senescence-like state.
Miller D; Kerkhofs K; Abbas-Aghababazadeh F; Madahar SS; Minden MD; Hébert J; Haibe-Kains B; Bayfield MA; Benchimol S
Cell Death Dis; 2023 Aug; 14(8):503. PubMed ID: 37543610
[TBL] [Abstract] [Full Text] [Related]
7. A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers.
Huang Y; Zhang Z; Sui M; Li Y; Hu Y; Zhang H; Zhang F
Front Immunol; 2023; 14():1202825. PubMed ID: 37409118
[TBL] [Abstract] [Full Text] [Related]
8. Environmental, social and behavioral risk factors in association with spatial clustering of childhood cancer incidence.
Hüls A; Van Cor S; Christensen GM; Li Z; Liu Y; Shi L; Pearce JL; Bayakly R; Lash TL; Ward K; Switchenko JM
Spat Spatiotemporal Epidemiol; 2023 Jun; 45():100582. PubMed ID: 37301597
[TBL] [Abstract] [Full Text] [Related]
9. Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia.
He C; Peng Z; Zhang D; Guo Y; Liang T; Zhao Y; Yu L; Zhang Q; Chang Z; Xiao Y; Li N; Xue H; Wu S; Zhao ZJ; Zhang C; Chen Y
Biochem Pharmacol; 2023 Jul; 213():115588. PubMed ID: 37187274
[TBL] [Abstract] [Full Text] [Related]
10. Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial.
Barbosa-Cortes L; Atilano-Miguel S; Martin-Trejo JA; Jiménez-Aguayo E; Martínez-Becerril FI; López-Alarcón M; Mejía Aranguré JM; Maldonado-Hernández J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Añoveros-Barrera A; Solis-Labastida KA; Bautista-Martinez BA; Juárez-Moya A; Hernández-Piñón Z; Espinoza Hernández LE; Núñez-Villegas NN; Jiménez-Hernández E; Pérez-Casillas RX
Front Endocrinol (Lausanne); 2023; 14():1120364. PubMed ID: 37124732
[TBL] [Abstract] [Full Text] [Related]
11. Detection and clinical significance of serum epo levels in patients with haematological tumours.
Zhao Y; Zhang W; Cong D; Bai Y
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):33-36. PubMed ID: 37114311
[TBL] [Abstract] [Full Text] [Related]
12. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract] [Full Text] [Related]
13. Mobile Source Benzene Regulations and Risk of Childhood and Young Adult Hematologic Cancers in Alaska: A Quasi-experimental Study.
Nethery RC; Vega S; Frazier AL; Laden F
Epidemiology; 2023 May; 34(3):385-388. PubMed ID: 36715968
[TBL] [Abstract] [Full Text] [Related]
14. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the timp1/PI3K/AKT/mTOR axis.
Tian Z; Tan Y; Lin X; Su M; Pan L; Lin L; Ou G; Chen Y
Transl Res; 2023 May; 255():66-76. PubMed ID: 36400307
[TBL] [Abstract] [Full Text] [Related]
15. Exploring Key Genes and Pathways of Cardiac Hypertrophy Based on Bioinformatics.
Zhang Z; Wang C
Dis Markers; 2022; 2022():2081590. PubMed ID: 36046382
[TBL] [Abstract] [Full Text] [Related]
16. An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene.
Valdez-Flores C; Erraguntla N; Budinsky R; Cagen S; Kirman CR
Chem Biol Interact; 2022 Oct; 366():110077. PubMed ID: 36029806
[TBL] [Abstract] [Full Text] [Related]
17. Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML.
Gyan E; Pigneux A; Hunault M; Peterlin P; Carré M; Bay JO; Bonmati C; Gallego-Hernanz MP; Lioure B; Bertrand P; Vallet N; Ternant D; Darrouzain F; Picou F; Béné MC; Récher C; Hérault O
Sci Rep; 2022 Jun; 12(1):9748. PubMed ID: 35697729
[TBL] [Abstract] [Full Text] [Related]
18. Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
Pemmaraju N; Garcia JS; Potluri J; Harb JG; Sun Y; Jung P; Qin QQ; Tantravahi SK; Verstovsek S; Harrison C
Lancet Haematol; 2022 Jun; 9(6):e434-e444. PubMed ID: 35576960
[TBL] [Abstract] [Full Text] [Related]
19. New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A; Bravo GM
Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
[TBL] [Abstract] [Full Text] [Related]
20. Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis.
Barrios-Ruiz A; Davila-Gonzalez D; Fountain E; Cheng L; Verstovsek S; Rojas-Hernandez CM
Sci Rep; 2022 Mar; 12(1):4674. PubMed ID: 35304527
[TBL] [Abstract] [Full Text] [Related]
[Next]
